{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T19:12:17Z","timestamp":1786821137667,"version":"build-2736575974"},"reference-count":151,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thyroid cancer is the most common cancer in the endocrine system. Most thyroid cancers have good prognosis, but some of them are resistant to treatment or show aggressive behavior. Like other tumors, thyroid cancers harbor tumor microenvironment (TME) composed of cancer associated fibroblasts (CAF) and immune cells. Autoimmune lymphocytic thyroiditis can occur in the thyroid, and it may be associated with cancer development. TME is involved in tumor progression through various mechanisms: (1) CAF is involved in tumor progression through cell proliferation and extracellular matrix (ECM) remodeling; and (2) immune cells are involved in tumor progression through cell proliferation, angiogenesis, epithelial mesenchymal transformation (EMT), and immune suppression. These events are activated by various cytokines, chemokines, and metabolites secreted from cells that comprise TME. This review is focused on how CAF and immune cells, two important cell components of thyroid cancer TME, are involved in tumor progression, and will explore their potential as therapeutic targets.<\/jats:p>","DOI":"10.3390\/ijms232012578","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T22:49:46Z","timestamp":1666306186000},"page":"12578","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Cell Component and Function of Tumor Microenvironment in Thyroid Cancer"],"prefix":"10.3390","volume":"23","author":[{"given":"Eunah","family":"Shin","sequence":"first","affiliation":[{"name":"Department of Pathology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4546-4709","authenticated-orcid":false,"given":"Ja Seung","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-med-061512-105739","article-title":"Thyroid cancer","volume":"65","author":"Carling","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the united states","volume":"140","author":"Davies","year":"2014","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737159.8.1.83","article-title":"Molecular genetics of thyroid cancer: Implications for diagnosis, treatment and prognosis","volume":"8","author":"Nikiforova","year":"2008","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrendo.2017.76","article-title":"Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies","volume":"13","author":"Molinaro","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: Esmo clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(17)30325-X","article-title":"Follicular thyroid cancer and h\u00fcrthle cell carcinoma: Challenges in diagnosis, treatment, and clinical management","volume":"6","author":"Grani","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2967\/jnumed.117.192559","article-title":"Controversial issues in thyroid cancer management","volume":"59","author":"Tuttle","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-16-0484","article-title":"Thyroid cancer: Risk-stratified management and individualized therapy","volume":"22","author":"Raue","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_11","first-page":"482","article-title":"Cancer associated fibroblasts: The dark side of the coin","volume":"1","author":"Cirri","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"Elyada","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"dmm029447","DOI":"10.1242\/dmm.029447","article-title":"A peek into cancer-associated fibroblasts: Origins, functions and translational impact","volume":"11","author":"LeBleu","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"655152","DOI":"10.3389\/fcell.2021.655152","article-title":"Cancer-associated fibroblast (caf) heterogeneity and targeting therapy of cafs in pancreatic cancer","volume":"9","author":"Geng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1100\/2011\/213962","article-title":"Macrophage polarization in health and disease","volume":"11","author":"Cassetta","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Montes, V.N., Turner, M.S., Subramanian, S., Ding, Y., Hayden-Ledbetter, M., Slater, S., Goodspeed, L., Wang, S., Omer, M., and Den Hartigh, L.J. (2013). T cell activation inhibitors reduce cd8+ t cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067709"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.1502055","article-title":"An m1-like macrophage polarization in decidual tissue during spontaneous preterm labor that is attenuated by rosiglitazone treatment","volume":"196","author":"Xu","year":"2016","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"L469","DOI":"10.1152\/ajplung.00158.2012","article-title":"Experimental pneumocystis lung infection promotes m2a alveolar macrophage-derived mmp12 production","volume":"303","author":"Nelson","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajpath.2014.09.022","article-title":"M2b macrophage elimination and improved resistance of mice with chronic alcohol consumption to opportunistic infections","volume":"185","author":"Ohama","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ki.2013.135","article-title":"Discrete functions of m2a and m2c macrophage subsets determine their relative efficacy in treating chronic kidney disease","volume":"84","author":"Lu","year":"2013","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/bjc.2015.292","article-title":"Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro","volume":"113","author":"Cao","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The m1 and m2 paradigm of macrophage activation: Time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fimmu.2019.01799","article-title":"Ontogeny of tumor-associated macrophages","volume":"10","author":"Laviron","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/imt-2016-0135","article-title":"Tumor-associated macrophages: Implications in cancer immunotherapy","volume":"9","author":"Petty","year":"2017","journal-title":"Immunotherapy"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fimmu.2018.01310","article-title":"Myeloid-derived suppressor cells hinder the anti-cancer activity of immune checkpoint inhibitors","volume":"9","author":"Weber","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of cd8+ t cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","article-title":"Immune stimulatory receptor cd40 is required for t-cell suppression and t regulatory cell activation mediated by myeloid-derived suppressor cells in cancer","volume":"70","author":"Pan","year":"2010","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108506","DOI":"10.1016\/j.intimp.2021.108506","article-title":"Blockade of cycloxygenase-2 ameliorates sepsis induced immune-suppression by regulating myeloid-derived suppressor cells","volume":"104","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"Pd-l1 is a novel direct target of hif-1\u03b1, and its blockade under hypoxia enhanced mdsc-mediated t cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by tgf-beta: \u201cN1\u201d versus \u201cn2\u201d tan","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/carcin\/bgs123","article-title":"Tumor-associated neutrophils: Friend or foe?","volume":"33","author":"Fridlender","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","article-title":"Tumor entrained neutrophils inhibit seeding in the premetastatic lung","volume":"20","author":"Granot","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","article-title":"Dendritic cells in cancer: The role revisited","volume":"45","author":"Veglia","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.13.11.1382","article-title":"Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis","volume":"13","author":"Coussens","year":"1999","journal-title":"Genes Dev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/PL00022372","article-title":"Mast cells and de novo angiogenesis: Angiogenic capability of individual mast-cell mediators such as histamine, tnf, il-8 and bfgf","volume":"46","author":"Norrby","year":"1997","journal-title":"Inflamm. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/modpathol.3800474","article-title":"Mast cells and cutaneous malignancies","volume":"19","author":"Wallis","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0714.2004.00297.x","article-title":"Characterization of mast cell subpopulations in lip cancer","volume":"34","author":"Rojas","year":"2005","journal-title":"J. Oral Pathol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2008-03-147033","article-title":"Scf-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment","volume":"112","author":"Huang","year":"2008","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.3748\/wjg.v11.i44.7054","article-title":"Immunosurveillance function of human mast cell?","volume":"11","author":"Ozdemir","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14728222.2018.1451514","article-title":"Foxp3+ treg as a therapeutic target for promoting anti-tumor immunity","volume":"22","author":"Whiteside","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.7150\/jca.44506","article-title":"Immune microenvironment of thyroid cancer","volume":"11","author":"Yin","year":"2020","journal-title":"J. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating cd8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: Receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fimmu.2014.00543","article-title":"Nkt cell networks in the regulation of tumor immunity","volume":"5","author":"Robertson","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e1168556","DOI":"10.1080\/2162402X.2016.1168556","article-title":"The immune network in thyroid cancer","volume":"5","author":"Galdiero","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fimmu.2019.01999","article-title":"Nk cell dysfunction and checkpoint immunotherapy","volume":"10","author":"Bi","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"Cd28 and ctla-4 have opposing effects on the response of t cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"Pd-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1440-1827.2002.01301.x","article-title":"Papillary carcinoma of the thyroid gland forming a myofibroblastic nodular tumor: Report of two cases and review of the literature","volume":"52","author":"Naganuma","year":"2002","journal-title":"Pathol. Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41379-020-0539-7","article-title":"Papillary thyroid carcinoma with prominent myofibroblastic stromal component: Clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases","volume":"33","author":"Suster","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1507\/endocrj.EJ17-0242","article-title":"Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases","volume":"64","author":"Takada","year":"2017","journal-title":"Endocr. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH643>3.0.CO;2-W","article-title":"Fibrosis in undifferentiated (anaplastic) thyroid carcinomas: Evidence for a dual action of tumour cells in collagen type i synthesis","volume":"191","author":"Dahlman","year":"2000","journal-title":"J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/hupa.2001.21138","article-title":"Pathologic features of hashimoto\u2019s-associated papillary thyroid carcinomas","volume":"32","author":"Rothstein","year":"2001","journal-title":"Hum. Pathol."},{"key":"ref_62","first-page":"442","article-title":"The incidence of thyroid carcinoma in hashimoto\u2019s thyroiditis","volume":"53","author":"Ott","year":"1987","journal-title":"Am. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"456027","DOI":"10.1155\/2015\/456027","article-title":"The warthin-like variant of papillary thyroid carcinoma: A comparison with classic type in the patients with coexisting hashimoto\u2019s thyroiditis","volume":"2015","author":"Yeo","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1016\/j.crad.2022.01.051","article-title":"Diffuse sclerosing variant of papillary thyroid carcinoma: Ultrasonographic and clinicopathological features in children\/adolescents and adults","volume":"77","author":"Wang","year":"2022","journal-title":"Clin. Radiol."},{"key":"ref_65","first-page":"3421","article-title":"The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland","volume":"80","author":"Matsubayashi","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_66","first-page":"1615","article-title":"In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer","volume":"82","author":"Fiumara","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2009-2564","article-title":"Tumor-associated lymphocytes and increased foxp3+ regulatory t cell frequency correlate with more aggressive papillary thyroid cancer","volume":"95","author":"French","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"570604","DOI":"10.3389\/fendo.2020.570604","article-title":"Immune cell confrontation in the papillary thyroid carcinoma microenvironment","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00405-018-5061-x","article-title":"Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: A predictive marker of cervical lymph node metastasis","volume":"275","author":"Cho","year":"2018","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1007\/s13277-015-4684-4","article-title":"Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma","volume":"37","author":"Sun","year":"2016","journal-title":"Tumour. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Minna, E., Brich, S., Todoerti, K., Pilotti, S., Collini, P., Bonaldi, E., Romeo, P., Cecco, L., Dugo, M., and Perrone, F. (2020). Cancer associated fibroblasts and senescent thyroid cells in the invasive front of thyroid carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12010112"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ryder, M., Gild, M., Hohl, T.M., Pamer, E., Knauf, J., Ghossein, R., Joyce, J.A., and Fagin, J.A. (2013). Genetic and pharmacological targeting of csf-1\/csf-1r inhibits tumor-associated macrophages and impairs braf-induced thyroid cancer progression. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054302"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-15-2351","article-title":"Fibroblast-mediated collagen remodeling within the tumor microenvironment facilitates progression of thyroid cancers driven by brafv600e and pten loss","volume":"76","author":"Jolly","year":"2016","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1038\/s41598-019-44361-6","article-title":"Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression","volume":"9","author":"Fozzatti","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/thy.2009.0017","article-title":"Fibroblast-mediated in vivo and in vitro growth promotion of tumorigenic rat thyroid carcinoma cells but not normal fisher rat thyroid follicular cells","volume":"19","author":"Saitoh","year":"2009","journal-title":"Thyroid"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.18632\/oncotarget.23388","article-title":"A dual mechanism of activation of the sonic hedgehog pathway in anaplastic thyroid cancer: Crosstalk with ras-braf-mek pathway and ligand secretion by tumor stroma","volume":"9","author":"Parascandolo","year":"2018","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1871520616666161031143301","article-title":"The warburg effect and the hallmarks of cancer","volume":"17","author":"Schwartz","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"57813","DOI":"10.18632\/oncotarget.18175","article-title":"The reverse warburg effect is likely to be an achilles\u2019 heel of cancer that can be exploited for cancer therapy","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the reverse warburg effect in cancer: Implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Semin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1010428317695922","DOI":"10.1177\/1010428317695922","article-title":"Glycolysis-related protein expression in thyroid cancer","volume":"39","author":"Nahm","year":"2017","journal-title":"Tumour. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/OTT.S294725","article-title":"Cancer-associated fibroblasts positively correlate with dedifferentiation and aggressiveness of thyroid cancer","volume":"14","author":"Wen","year":"2021","journal-title":"Onco. Targets Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/thy.2011.0452","article-title":"Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma","volume":"22","author":"Qing","year":"2012","journal-title":"Thyroid"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4132\/jptm.2015.06.01","article-title":"Cancers with higher density of tumor-associated macrophages were associated with poor survival rates","volume":"49","author":"Jung","year":"2015","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1677\/ERC-08-0036","article-title":"Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer","volume":"15","author":"Ryder","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3803\/EnM.2013.28.3.192","article-title":"The expression of tumor-associated macrophages in papillary thyroid carcinoma","volume":"28","author":"Kim","year":"2013","journal-title":"Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/carcin\/bgu060","article-title":"Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing cxcl8","volume":"35","author":"Fang","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Huang, F.J., Zhou, X.Y., Ye, L., Fei, X.C., Wang, S., Wang, W., and Ning, G. (2016). Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing ccl15. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2114-7"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2265.2012.04482.x","article-title":"Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma","volume":"77","author":"Cunha","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/mco.2013.170","article-title":"Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer","volume":"1","author":"Suzuki","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/thy.2015.0289","article-title":"Circulating myeloid-derived suppressor cells predict differentiated thyroid cancer diagnosis and extent","volume":"26","author":"Angell","year":"2016","journal-title":"Thyroid"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.7150\/ijms.28498","article-title":"An increased neutrophil-to-lymphocyte ratio predicts incomplete response to therapy in differentiated thyroid cancer","volume":"15","author":"Lee","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00268-014-2630-z","article-title":"Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?","volume":"38","author":"Lang","year":"2014","journal-title":"World J. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Galdiero, M.R., Varricchi, G., Loffredo, S., Bellevicine, C., Lansione, T., Ferrara, A.L., Iannone, R., di Somma, S., Borriello, F., and Clery, E. (2018). Potential involvement of neutrophils in human thyroid cancer. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199740"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1309\/AJCPAKYDO56NKMYZ","article-title":"The role of s100-positive dendritic cells in the prognosis of papillary thyroid carcinoma","volume":"139","author":"Hilly","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12020-012-9853-2","article-title":"Regulatory t cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter","volume":"44","author":"Yu","year":"2013","journal-title":"Endocrine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.prp.2015.05.009","article-title":"Cd1a-positive dendritic cell density predicts disease-free survival in papillary thyroid carcinoma","volume":"211","author":"Hilly","year":"2015","journal-title":"Pathol. Res. Pract."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0002-9440(10)64951-6","article-title":"Papillary carcinoma of the thyroid: Hepatocyte growth factor (hgf) stimulates tumor cells to release chemokines active in recruiting dendritic cells","volume":"156","author":"Scarpino","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1038\/onc.2010.348","article-title":"Mast cells have a protumorigenic role in human thyroid cancer","volume":"29","author":"Melillo","year":"2010","journal-title":"Oncogene"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1038\/onc.2014.441","article-title":"Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an il-8-akt-slug pathway","volume":"34","author":"Visciano","year":"2015","journal-title":"Oncogene"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1089\/thy.2011.0059","article-title":"Higher intratumoral expression of cd1a, tryptase, and cd68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: Correlation with clinical and pathological parameters","volume":"21","author":"Proietti","year":"2011","journal-title":"Thyroid"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12094-014-1222-6","article-title":"Analysis of regulatory t cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without hashimoto\u2019s thyroiditis","volume":"17","author":"Liu","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"E934","DOI":"10.1210\/jc.2011-3428","article-title":"Programmed death-1+ t cells and regulatory t cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer","volume":"97","author":"French","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1089\/thy.2013.0423","article-title":"Expression of indoleamine 2,3-dioxygenase and infiltration of foxp3+ regulatory t cells are associated with aggressive features of papillary thyroid microcarcinoma","volume":"24","author":"Ryu","year":"2014","journal-title":"Thyroid"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.6061\/clinics\/2012(05)13","article-title":"Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas","volume":"67","author":"Cunha","year":"2012","journal-title":"Clinics"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-13-0436","article-title":"Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity","volume":"21","author":"Imam","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.imlet.2014.07.005","article-title":"The prevalence and distribution of th17 and tc17 cells in patients with thyroid tumor","volume":"162","author":"Jiang","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/cen.12586","article-title":"Cd8+ tumour-infiltrating lymphocytes and cox2 expression may predict relapse in differentiated thyroid cancer","volume":"83","author":"Cunha","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.18632\/aging.102780","article-title":"Immune-related key gene cldn10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma","volume":"12","author":"Xiang","year":"2020","journal-title":"Aging"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/jc.2011-1838","article-title":"Phenotypical analysis of lymphocytes with suppressive and regulatory properties (tregs) and nk cells in the papillary carcinoma of thyroid","volume":"97","author":"Gogali","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.intimp.2018.09.016","article-title":"Dysfunction of natural killer cells mediated by pd-1 and tim-3 pathway in anaplastic thyroid cancer","volume":"64","author":"Yin","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/1078-0432.CCR-14-0291","article-title":"Human anaplastic thyroid carcinoma cells are sensitive to nk cell-mediated lysis via ulbp2\/5\/6 and chemoattract nk cells","volume":"20","author":"Wennerberg","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3389\/fimmu.2017.00816","article-title":"Natural killer cell (nk-92mi)-based therapy for pulmonary metastasis of anaplastic thyroid cancer in a nude mouse model","volume":"8","author":"Zhu","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_114","unstructured":"(2014). Integrated genomic characterization of papillary thyroid carcinoma. Cell, 159, 676\u2013690."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/ERC-17-0532","article-title":"Immune landscape of papillary thyroid cancer and immunotherapeutic implications","volume":"25","author":"Na","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1089\/thy.2014.0134","article-title":"Braf v600e in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration","volume":"24","author":"Angell","year":"2014","journal-title":"Thyroid"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/ERC-16-0421","article-title":"Comprehensive screening for pd-l1 expression in thyroid cancer","volume":"24","author":"Ahn","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1074\/jbc.M116.745448","article-title":"Signal transducer and activator of transcription 1 plays a pivotal role in ret\/ptc3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1","volume":"292","author":"Moretti","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"9602","DOI":"10.12659\/MSM.918519","article-title":"Identification of key genes in thyroid cancer microenvironment","volume":"25","author":"Zhao","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the \u2018immunoscore\u2019 in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J. Pathol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40425-015-0088-7","article-title":"Ncounter(\u00ae) pancancer immune profiling panel (Nanostring Technologies, Inc., Seattle, WA)","volume":"3","author":"Cesano","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_125","first-page":"3557","article-title":"Immune profiling of thyroid carcinomas suggests the existence of two major phenotypes: An atc-like and a pdtc-like","volume":"104","author":"Giannini","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_126","first-page":"1418","article-title":"Targeting tgf-\u03b21 suppresses survival of and invasion by anaplastic thyroid carcinoma cells","volume":"9","author":"Sun","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_127","first-page":"2196","article-title":"Targeting tgf-\u03b21 inhibits invasion of anaplastic thyroid carcinoma cell through smad2-dependent s100a4-mmp-2\/9 signalling","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2005.07.012","article-title":"Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model","volume":"238","author":"She","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Lu, Y., Zhu, Y., Deng, S., Chen, Y., Li, W., Sun, J., and Xu, X. (2021). Targeting the sonic hedgehog pathway to suppress the expression of the cancer stem cell (csc)-related transcription factors and csc-driven thyroid tumor growth. Cancers, 13.","DOI":"10.3390\/cancers13030418"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hed.20816","article-title":"Small molecule c-met inhibitor pha665752: Effect on cell growth and motility in papillary thyroid carcinoma","volume":"30","author":"Chattopadhyay","year":"2008","journal-title":"Head. Neck."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1535-7163.MCT-13-0187","article-title":"Off-target effects of c-met inhibitors on thyroid cancer cells","volume":"13","author":"Zhou","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/hed.24461","article-title":"Antitumor effect of cxcr4 antagonist amd3100 on the tumorigenic cell line of bhp10-3 papillary thyroid cancer cells","volume":"38","author":"Jung","year":"2016","journal-title":"Head. Neck."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1139\/bcb-2017-0074","article-title":"The cxcl12-cxcr4 axis promotes migration, invasiveness, and emt in human papillary thyroid carcinoma b-cpap cells via nf-\u03bab signaling","volume":"96","author":"Lin","year":"2018","journal-title":"Biochem. Cell Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.surg.2015.10.016","article-title":"Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target","volume":"159","author":"Shirley","year":"2016","journal-title":"Surgery"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1535-7163.MCT-05-0078","article-title":"Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer","volume":"4","author":"Younes","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.12659\/MSM.898702","article-title":"Targeting transforming growth factor-beta1 (tgf-\u03b21) inhibits tumorigenesis of anaplastic thyroid carcinoma cells through erk1\/2-nf\u03bakb-puma signaling","volume":"22","author":"Yin","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1210\/jc.2002-020830","article-title":"Analysis of cancer\/testis antigens in sporadic medullary thyroid carcinoma: Expression and humoral response to ny-eso-1","volume":"88","author":"Maio","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1089\/thy.2013.0680","article-title":"A potential role for immunotherapy in thyroid cancer by enhancing ny-eso-1 cancer antigen expression","volume":"24","author":"Gunda","year":"2014","journal-title":"Thyroid"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fendo.2020.00490","article-title":"A case report of sequential use of a yeast-cea therapeutic cancer vaccine and anti-pd-l1 inhibitor in metastatic medullary thyroid cancer","volume":"11","author":"Donahue","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Jiang, K., Song, C., Kong, L., Hu, L., Lin, G., Ye, T., Yao, G., Wang, Y., Chen, H., and Cheng, W. (2018). Recombinant oncolytic newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4522-3"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2014.07.009","article-title":"The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses","volume":"190","author":"Mundi","year":"2014","journal-title":"Virus. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.18632\/oncotarget.6430","article-title":"The oncolytic virus dl922-947 reduces il-8\/cxcl8 and mcp-1\/ccl2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma","volume":"7","author":"Passaro","year":"2016","journal-title":"Oncotarget"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/thy.2006.0178","article-title":"Results of a phase i clinical study using dendritic cell vaccinations for thyroid cancer","volume":"17","author":"Kuwabara","year":"2007","journal-title":"Thyroid"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1158\/1078-0432.CCR-03-0698","article-title":"Dendritic cell vaccination in medullary thyroid carcinoma","volume":"10","author":"Stift","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/1078-0432.CCR-17-2008","article-title":"Car t therapy targeting icam-1 eliminates advanced human thyroid tumors","volume":"23","author":"Min","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/s41598-019-46938-7","article-title":"Manufacturing and preclinical validation of car t cells targeting icam-1 for advanced thyroid cancer therapy","volume":"9","author":"Vedvyas","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Mehnert, J.M., Varga, A., Brose, M.S., Aggarwal, R.R., Lin, C.C., Prawira, A., de Braud, F., Tamura, K., Doi, T., and Piha-Paul, S.A. (2019). Safety and antitumor activity of the anti-pd-1 antibody pembrolizumab in patients with advanced, pd-l1-positive papillary or follicular thyroid cancer. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5380-3"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-018-0378-y","article-title":"Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma","volume":"6","author":"Iyer","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41416-018-0296-2","article-title":"Combinations of braf inhibitor and anti-pd-1\/pd-l1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer","volume":"119","author":"Gunda","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1158\/1078-0432.CCR-20-1523","article-title":"Pd1 blockade enhances icam1-directed car t therapeutic efficacy in advanced thyroid cancer","volume":"26","author":"Gray","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Otoshi, T., Nagano, T., Tachihara, M., and Nishimura, Y. (2019). Possible biomarkers for cancer immunotherapy. Cancers, 11.","DOI":"10.3390\/cancers11070935"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12578\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:57:51Z","timestamp":1760144271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":151,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms232012578"],"URL":"https:\/\/doi.org\/10.3390\/ijms232012578","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}